Labiotech.eu

oncolytic virus cancer treatment transgene sillajen

News and Trends 2 Aug 2019

Oncolytic Virus for Liver Cancer Ruled Futile in Phase III

A phase III trial testing an oncolytic virus treatment for liver cancer, developed by the French biotech Transgene, has been discontinued after interim analyses concluded that the treatment was unlikely to succeed. Originally expected to finish in 2020, the phase III trial tested the oncolytic virus treatment Pexa-Vec in patients with the liver cancer hepatocellular […]

August 2, 2019 - 2 minutesmins - By Jonathan Smith

acute respiratory distress syndrome pantherna berlin inflammatory disease

Startup Scout 2 Aug 2019

This Biotech Uses Messenger RNA to Treat Lethal Lung Inflammation

Based close to Berlin, Germany, the biotech startup Pantherna Therapeutics is developing a messenger RNA drug to treat a life-threatening lung condition that requires mechanical ventilation. Mission: To develop a messenger RNA (mRNA) drug to treat acute respiratory distress syndrome, an inflammatory lung reaction that kills up to half of patients with the condition. Acute […]

August 2, 2019 - 4 minutesmins - By Jonathan Smith

atlantic healthcare pouchitis inflammatory bowel disease

More News! 1 Aug 2019

Atlantic Healthcare’s Inflammatory Bowel Disease RNA Drug Fails Phase III

Hopes of seeing an approved treatment for the inflammatory bowel condition pouchitis have been dashed as the UK company Atlantic Healthcare’s RNA drug has proved ineffective in a phase III trial. The trial tested Atlantic Healthcare’s RNA drug alicaforsen as a treatment for patients with pouchitis. Patients with this condition have their colon surgically replaced […]

August 1, 2019 - 2 minutesmins - By Jonathan Smith

Expert Advice 1 Aug 2019

How to Use Case Studies to Take Your Life Science Marketing Strategy to the Next Level

To build a great relationship with a business partner, laying a foundation of trust is essential. But how can a potential partner trust you if they have no concept of how you work? Case studies can help communicate trust and show your potential partner how they can improve their life science marketing strategy by working […]

August 1, 2019 - 6 minutesmins - By Larissa Warneck-Silvestrin

inflammatory bowel disease treatment personalized medicine predictimmune

News and Trends 31 Jul 2019

British Biotech Raises €11M to Market Personalized Medicine Test

The UK biotech PredictImmune has raised €11M (£10M) in a Series B fundraising round to commercialize technology to predict the progress of inflammatory bowel disease in newly diagnosed patients. The funds will finance the global launch of PredictSURE IBD, a blood test that can identify patients with the most severe cases of inflammatory bowel disease, […]

July 31, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 31 Jul 2019

Wellington Partners Raises €210M to Invest in European Life Sciences

VC firm Wellington Partners has raised its fifth fund dedicated to investing in life science companies, with a major focus on those located in German-speaking countries. Wellington Partners has well surpassed its initial target of €150M for its fifth life sciences fund. With a total €210M raised, this new fund is more than double the […]

July 31, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 31 Jul 2019

French Biotech’s Insulin Resistance Treatment Boosted by €67M Series A

The French company Alizé Pharma III has raised a Series A round of €67M to push two peptide drugs into phase I, including a drug treating rare genetic conditions causing insulin resistance. The money will advance Alizé Pharma III’s two preclinical drugs into clinical trials, with phase I trials expected to begin in 2020. One […]

July 31, 2019 - 2 minutesmins - By Jonathan Smith

Interview 30 Jul 2019

The First Approved NASH Therapy?

Genfit is poised to become the first company to get a treatment for NASH to market — something that could happen as early as 2020, should its late 2019 phase III trial results be positive. I spoke to Dean Hum, the current COO and CSO of Genfit, to find out more about the company’s 20-year […]

July 30, 2019 - 6 minutesmins - By Helen Albert

agrosavfe belgium strawberry pesticide fungal

News and Trends 30 Jul 2019

Belgian Biotech Raises €35M to Develop Eco-Friendly Pesticides

The Belgium-based company AgroSavfe has raised a Series C round of €35M to develop an environmentally friendly crop pesticide inspired by llama antibodies. AgroSavfe will use the funds to develop and manufacture its lead protein fungicide on a commercial scale. The company aims to get approval from the US Environmental Protection Agency and launch the […]

July 30, 2019 - 2 minutesmins - By Jonathan Smith

Expert Advice 30 Jul 2019

How to Build a Winning Life Science Content Marketing Strategy

The data are in. Content works. As the internet matured, buyers in all industries began educating themselves before making a buying decision. When prospects get in touch with you, they’ve likely made up their mind already. How, then, can you affect their decision? “Publish or perish” has been standard advice for scientists since the early […]

July 30, 2019 - 12 minutesmins - By James Mathison

News and Trends 29 Jul 2019

€43M Series C to Launch UK Company’s Home Hemodialysis Kit

Quanta Dialysis Technologies has raised €43.2M ($48M) to fund the commercial launch of a device that makes home hemodialysis more straightforward and economical for kidney failure patients. The UK-based Quanta will use the money to launch its technology in the UK later this year, and also apply for FDA approval. The technology previously obtained a […]

July 29, 2019 - 2 minutesmins - By Jonathan Smith

Startup Scout 26 Jul 2019

This Biotech Makes Food for Space Missions Using Bacteria

Time to head to Helsinki, Finland, this week! We’re visiting Solar Foods, a biotech using bacteria to produce protein-rich flour out of carbon dioxide and water. Mission: To develop a protein-rich powder that can be made with little more than bacteria, electricity and water. This production method could be more efficient and sustainable than traditional […]

July 26, 2019 - 3 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Oncolytic Virus for Liver Cancer Ruled Futile in Phase III

This Biotech Uses Messenger RNA to Treat Lethal Lung Inflammation

Atlantic Healthcare’s Inflammatory Bowel Disease RNA Drug Fails Phase III

How to Use Case Studies to Take Your Life Science Marketing Strategy to the Next Level

British Biotech Raises €11M to Market Personalized Medicine Test

Wellington Partners Raises €210M to Invest in European Life Sciences

French Biotech’s Insulin Resistance Treatment Boosted by €67M Series A

The First Approved NASH Therapy?

Belgian Biotech Raises €35M to Develop Eco-Friendly Pesticides

How to Build a Winning Life Science Content Marketing Strategy

€43M Series C to Launch UK Company’s Home Hemodialysis Kit

This Biotech Makes Food for Space Missions Using Bacteria

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!